University of Miami's 2nd Biennial Miami Leukemia Symposium

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

2020 Update on Combination Therapies in R/R CLL: Venetoclax +R, Venetoclax + BTKi, Venetoclax + PI3Ki & BTKi + PI3Ki

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Matthew Davids
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Matthew Davids
56 views
May 14, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
CLL Therapy in 2019
13:16

Advances in the CLL Frontline Therapy: BTK Inhibitors vs. Chemoimmun…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Woyach

154 views
07:09

The Big Question in CLL Frontline Therapy: How to Choose Between Ibr…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Woyach

282 views
24:51

2020 Update on Combination Therapies in R/R CLL: Venetoclax +R, Vene…

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Davids

56 views